Pharma Journalist -

Amblyotech, a US-based digital therapeutics company, announced that it has completed the sale of all of its outstanding shares to Novartis pursuant to a Share Purchase Agreement entered…
Read More...

Alexion Pharmaceuticals, Inc. announced plans to initiate a global Phase 3 study to investigate ULTOMIRIS (ravulizumab-cwvz) in a subset of adults with COVID-19 – those who are…
Read More...

Wavelength Pharmaceuticals, a leading supplier of active pharmaceutical ingredients (APIs), reported that it has greatly expanded production of APIs for certain pharmaceutical products…
Read More...

Roche announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and the European Medicines Agency (EMA) has…
Read More...

RedHill Biopharma Ltd. announced that it has entered into an agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health…
Read More...

SOM Biotech announces the in vitro validation of three drug candidates as new therapies for the treatment of COVID-19. The three candidates inhibit the main protease of SARS-CoV-2 and…
Read More...

Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial with approximately 440 patients to evaluate the use of…
Read More...

SMi Reports: The upcoming Highly Potent Active Pharmaceutical Ingredients conference is now via remote access only – 3 weeks to go Due to the COVID-19 outbreak, SMi Group has made…
Read More...

According to the website of the U.S. Food and Drug Administration ("FDA"), Shanghai Fosun Pharmaceutical (Group) Co., Ltd  has received emergency use authorization (EUA) from FDA for…
Read More...

Incyte announced the initiation of RUXCOVID, a global, randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating the efficacy and safety of ruxolitinib (Jakafi)…
Read More...